Skip to main content

Table 8 Transcriptional alterations of solute carriers (SLCs).

From: Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes

SLCs

Solute(s)

#A-s tsc

A-s cpm

#A/B -c tsc

A-c cpm

B-c cpm

#B-s tsc

B-s cpm

(A-s + A-c) cpm

(B-s + B-c) cpm

B – A cpm

Slc25a5

adenine nucleotide (ATP/ADP)

1

15

1

842

2631

3

109

857

2740

1883

Slc3a2

neutral amino acids

2

44

2

1553

1305

5

152

1597

1457

-140

Slc25a3

phosphate

0

0

2

1423

1174

1

43

1423

1217

-206

Slc25a11

2-oxoglutarate/malate

1

15

1

131

120

2

33

146

153

7

Slc20a2

phosphate

1

15

1

189

120

2

22

204

142

-62

Slc2a1

glucose

1

15

1

15

120

0

0

30

120

90

Slc31a1

copper

1

15

1

58

98

0

0

73

98

25

Slc30a9

zinc

1

15

1

29

65

0

0

44

65

21

Slc12a4

K+/Cl-

1

15

1

44

54

0

0

59

54

-5

Slc35a2

UDP-galactose

1

15

0

0

0

2

54

15

54

39

Slc25a17

adenine nucleotide

1

15

1

116

33

0

0

131

33

-98

Slc25a19

adenine nucleotide

2

29

1

44

33

0

0

73

33

-40

Slc9a3r1

Na+/H+ exchanger

2

29

1

116

11

1

11

145

22

-123

Slc6a9

neurotransmitter, glycine

0

0

1

15

22

0

0

15

22

7

Slc35c2

neutral amino acids

0

0

1

58

11

0

0

58

11

-47

Slc39a6

zinc

1

15

1

15

11

0

0

30

11

-19

Slc6a15

neurotransmitter, aa, osmolytes

0

0

0

0

0

1

109

0

109

109

Slc25a13

aa Q and E

0

0

0

0

0

3

76

0

76

76

Slc2a8

glucose

0

0

0

0

0

1

54

0

54

54

Slco3a1

organic anion

0

0

0

0

0

1

43

0

43

43

Slc35a4

UDP-galactose

0

0

0

0

0

1

33

0

33

33

Slc41a3

mg++

0

0

0

0

0

1

33

0

33

33

Slc12a5

Na+/Cl-

0

0

0

0

0

1

22

0

22

22

Slc25a10

citrate/malate, dicarboxylate

0

0

0

0

0

1

22

0

22

22

Slc27a4

fatty acids

0

0

0

0

0

1

22

0

22

22

Slc37a3

glycerol-3-P

0

0

0

0

0

1

22

0

22

22

Slc37a4

glycerol-6-P

0

0

0

0

0

1

22

0

22

22

Slc4a2

anion

0

0

0

0

0

1

22

0

22

22

Slc7a7

cation amino acid

0

0

0

0

0

1

22

0

22

22

Slc35a1

CMP-Sialic acid

2

87

0

0

0

0

0

87

0

-87

Slc37a2

glycerol-3-P

4

73

0

0

0

0

0

73

0

-73

Slc15a4

peptide

1

58

0

0

0

0

0

58

0

-58

Slc25a1

citrate

2

58

0

0

0

0

0

58

0

-58

Slc37a1

glycerol-3-P

1

44

0

0

0

0

0

44

0

-44

Slc10a3

Na+/bile acid

2

29

0

0

0

0

0

29

0

-29

Slc22a18

organic cation

1

29

0

0

0

0

0

29

0

-29

Slc33a1

acetyl-CoA

2

29

0

0

0

0

0

29

0

-29

Slc39a1

zinc

1

29

0

0

0

0

0

29

0

-29

Slc39a11

metal ion

1

29

0

0

0

0

0

29

0

-29

Slc39a3

zinc

1

29

0

0

0

0

0

29

0

-29

Slc4a8

anion

1

29

0

0

0

0

0

29

0

-29

Slc6a6

taurine

2

29

0

0

0

0

0

29

0

-29

Slco4a1

anion

1

29

0

0

0

0

0

29

0

-29

  1. 'A', Melan-a2 melanocytes; 'B', B16F1 melanoma cells; A/B, for both A and B; '#', number of transcripts; 's', specific; 'c', common; 'tsc', transcript; 'cpm', PET counts per million; upper panel, common; central panel, melanoma-specific; lower panel, melanocyte-specific; SLCs with PET counts less than 20 cpm for both libraries were excluded.